NCT03845478 is a NA clinical trial of Control Group (CG) in Overweight, sponsored by Universidad de Córdoba.

Who is sponsoring NCT03845478?

NCT03845478 is sponsored by Universidad de Córdoba.

What drugs are being tested in NCT03845478?

Interventions in NCT03845478: Control Group (CG), Intervention Group (IG).

What condition does NCT03845478 study?

NCT03845478 studies Overweight, Obesity.

Is NCT03845478 still recruiting?

NCT03845478 is currently status unknown. Last updated 20 February 2019.

Last reviewed 2019-02-20 · How we verify

NCT03845478

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of the Prescription of 10,000 Steps Per Day Using a Pedometer APP in the Body Composition of Overweight Adults

Status unknown NA Last updated 20 February 2019

What this trial tests

NA trial testing Control Group (CG) in Overweight in 120 participants. Status unknown.

Timeline

1 January 2016

Primary endpoint
15 December 2018

1 June 2019

Quick facts

Lead sponsor	Universidad de Córdoba
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	120
Start date	1 January 2016
Primary completion	15 December 2018
Estimated completion	1 June 2019

Drugs / interventions tested

Control Group (CG)
Intervention Group (IG)

Conditions studied

Overweight — all drugs for Overweight →
Obesity — all drugs for Obesity →

Sponsor

Universidad de Córdoba

Who can join

Adults 18 to 65, any sex, with Overweight or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed the effect of the Accupedo pedometer smartphone app intervention, with goal setting of walking prescription of 10,000 steps per day, in overweight adults.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of an mHealth Intervention Using a Pedometer App With Full In-Person Counseling on Body Composition of Overweight Adults: Randomized Controlled Weight Loss Trial.
Hernández-Reyes A, Cámara-Martos F, Molina-Luque R, Moreno-Rojas R. · · 2020 · cited 8× · PMID 32348263 · DOI 10.2196/16999

Verify or expand the search:

Other trials of Control Group (CG)

Trials testing the same drug.

NCT07277803 — Device-Based vs Manual Sensory Training in Low Back Pain · NA · not yet recruiting
NCT06848517 — Synchronous and Asynchronous Telerehabilitation for Women With Urinary Incontinence · NA · recruiting
NCT06839482 — Robotic Rehabilitation of the Upper Limb in Subacute Stroke · NA · recruiting
NCT07505225 — Effects of Interventions on Child's Pain, Physiological, and Psychological Responses During Venous Catheterization · NA · completed
NCT06732778 — Effectiveness of Pain Neuroscience Education in Women With Menstrual Pain · NA · completed

Other recruiting trials for Overweight

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting

Other Universidad de Córdoba trials

Trials by the same sponsor.

NCT06958094 — Effectiveness of Gamified Mobile Health Apps for Airway Clearance Therapy in Children and Adolescents With Cystic Fibros · NA · not yet recruiting
NCT06409962 — A New Technological Intervention to Address Childhood Obesity: · NA · recruiting
NCT06196866 — Effectiveness of Exergaming in Adittion to Conventional Treatment for Physical Therapy in People with Multiple Sclerosis · NA · active not recruiting
NCT05289258 — Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive Impairments · NA · recruiting
NCT04366401 — Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03845478 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Córdoba
Last refreshed: 20 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03845478.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing